Literature DB >> 20547989

Castration-resistant prostate cancer: descriptive yet pejorative?

E David Crawford, Daniel Petrylak.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20547989     DOI： 10.1200/JCO.2010.28.7664

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  9 in total

1.  c-Jun NH2-terminal kinase-induced proteasomal degradation of c-FLIPL/S and Bcl2 sensitize prostate cancer cells to Fas- and mitochondria-mediated apoptosis by tetrandrine.

Authors:  Pankaj Chaudhary; Jamboor K Vishwanatha
Journal:  Biochem Pharmacol       Date:  2014-08-30       Impact factor: 5.858

Review 2.  Current and emerging therapies for bone metastatic castration-resistant prostate cancer.

Authors:  Jeremy S Frieling; David Basanta; Conor C Lynch
Journal:  Cancer Control       Date:  2015-01       Impact factor: 3.302

3.  Proteomic profiling of androgen-independent prostate cancer cell lines reveals a role for protein S during the development of high grade and castration-resistant prostate cancer.

Authors:  Punit Saraon; Natasha Musrap; Daniela Cretu; George S Karagiannis; Ihor Batruch; Chris Smith; Andrei P Drabovich; Dominique Trudel; Theodorus van der Kwast; Colm Morrissey; Keith A Jarvi; Eleftherios P Diamandis
Journal:  J Biol Chem       Date:  2012-08-20       Impact factor: 5.157

4.  Quantitative proteomics reveals that enzymes of the ketogenic pathway are associated with prostate cancer progression.

Authors:  Punit Saraon; Daniela Cretu; Natasha Musrap; George S Karagiannis; Ihor Batruch; Andrei P Drabovich; Theodorus van der Kwast; Atsushi Mizokami; Colm Morrissey; Keith Jarvi; Eleftherios P Diamandis
Journal:  Mol Cell Proteomics       Date:  2013-02-26       Impact factor: 5.911

5.  HMGB1 promotes tumor progression and invasion through HMGB1/TNFR1/NF-κB axis in castration-resistant prostate cancer.

Authors:  Ae Ryang Jung; Ga Eun Kim; Mee Young Kim; U-Syn Ha; Sung-Hoo Hong; Ji Youl Lee; Sae Woong Kim; Yong Hyun Park
Journal:  Am J Cancer Res       Date:  2021-05-15       Impact factor: 6.166

6.  Inhibition of hedgehog and androgen receptor signaling pathways produced synergistic suppression of castration-resistant prostate cancer progression.

Authors:  Pramod S Gowda; Jianhong D Deng; Sweta Mishra; Abhik Bandyopadhyay; Sitai Liang; Shu Lin; Devalingam Mahalingam; Lu-Zhe Sun
Journal:  Mol Cancer Res       Date:  2013-08-29       Impact factor: 5.852

Review 7.  Castration-resistant prostate cancer: systemic therapy in 2012.

Authors:  Fernando C Maluf; Oren Smaletz; Daniel Herchenhorn
Journal:  Clinics (Sao Paulo)       Date:  2012       Impact factor: 2.365

8.  PRKAR2B plays an oncogenic role in the castration-resistant prostate cancer.

Authors:  Jianjun Sha; Wei Xue; Baijun Dong; Jiahua Pan; Xiaorong Wu; Dong Li; Dongming Liu; Yiran Huang
Journal:  Oncotarget       Date:  2017-01-24

9.  Mechanisms of Androgen-Independent Prostate Cancer.

Authors:  Punit Saraon; Andrei P Drabovich; Keith A Jarvi; Eleftherios P Diamandis
Journal:  EJIFCC       Date:  2014-04-28
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.